Myasthenia gravis (MG) is a rare autoimmune disease characterized by skeletal muscle weakness and fatigue; it involves the production of autoantibodies directed against the postsynaptic nicotinic acetylcholine receptor (AChR) and muscle-specific receptor tyrosine kinase (Musk) [1]. The gene discussed is MUSK; the disease is myasthenia gravis.